Related Experiment Video
Updated: Jun 16, 2026
08:30
Detection of Phospholipase C Activity in the Brain Homogenate from the Honeybee
Published on: September 14, 2018
Phosphonates as Modulators of Brain Chemistry
Susana Santos Braga1, Nádia E Santos1,2, Maria Almeida-Santos1
1LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Aveiro, Portugal.
Medicinal Research Reviews
|June 14, 2026
Summary
Phosphonates show promise for treating brain diseases like Alzheimer's and ischemic injury by mimicking phosphates. Further research into their stability and versatility could unlock new therapeutic strategies for neurological disorders.
Area of Science:
- Medicinal chemistry
- Neuroscience
- Drug discovery
Background:
- Phosphonates, structurally similar to phosphates, interact with vital brain processes.
- Their therapeutic potential in neurological diseases remains an underexplored area of medicinal chemistry.
Purpose of the Study:
- To review current knowledge on phosphonates for brain disease therapeutics.
- To highlight applications in Alzheimer's disease and ischemic brain injury.
- To discuss future research directions for phosphonate-based neurological treatments.
Main Methods:
- Literature review of phosphonate applications in neuroscience.
- Analysis of phosphonates targeting cholinesterase, amyloid-β interactions, and glutamate receptors.
- Examination of phosphonate-based diagnostic platforms.
Main Results:
- Phosphonates are investigated for Alzheimer's disease as cholinesterase inhibitors and agents targeting amyloid-β interactions.
- Phosphonate-based materials show utility in Alzheimer's diagnostics.
- Phosphonates targeting NMDA and AMPA receptors are explored for ischemic brain injury, with mGlu-4 receptor agonists showing neuroregenerative potential.
Conclusions:
- Phosphonates offer versatile therapeutic potential for brain disorders due to their stability and phosphate-mimicking properties.
- Further research is needed to address knowledge gaps and optimize phosphonate development for neurological conditions.
Related Concept Videos
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:02Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
01:02Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...